Dr. Goreti Ribeiro Morais

Goreti Ribeiro Morais obtained her degree in Pharmaceutical Sciences from the University of Coimbra and received her PhD in Pharmaceutical Chemistry from the University of Lisbon (Portugal)/University of Kyushu (Japan). Then she conducted a three-year postdoctoral stay at the Institute of Cancer Therapeutics (ICT), University of Bradford followed by a research scientist position at the Radiopharmaceutical Sciences Group/Technical University of Lisbon. In late 2014 she moved back at the ICT as senior PDRA to integrate the Yorkshire Cancer Research Programme grant. She made significant contributions towards three main medicinal chemistry projects (polysialyltransferase inhibitors, Cytochromes P450-activated prodrugs, and MMP-activated prodrugs) of the ICT and was crucial for the strengthening of the collaborations with Stanford University, Incanthera and Ellipses Pharma. Since 2019 she has played a key role in the successful Incanthera-funded doctoral Training centre (DTC-ICT). In addition to the training and mentoring of the medicinal chemistry postgraduate students of the ICT, she acted as formal co-supervisor of three PhD students (each successfully completed, and have secured excellent jobs in industry (2) and academia (1), three MSc students and four international undergraduate students. Currently she is co-supervisor of one PhD student and two MSc students. She has authored 52 peer-reviewed journal articles, 7 of which as corresponding author, 1 book chapter, 1 patent and 18 published abstracts in international conferences. Moreover, she has teaching responsibilities in three Master courses and holds a PAT role for MPharm and postgraduate (MSc) students.